SPRINT
2015
Systolic Blood Pressure Intervention Trial
In 9,361 high-risk non-diabetic hypertensive adults, intensive BP control to SBP < 120 mm Hg reduced CV events and all-cause mortality compared with standard control to SBP < 140 mm Hg.
Result
Efficacy: MI, ACS, stroke, HF or CV deathHR 0.75
Below 1 favours intensive BP control to SBP < 120 mm Hg, above 1 favours standard control to SBP < 140 mm Hg.
Event rates Intensive BP control to SBP < 120 mm Hg 1.65% vs standard control to SBP < 140 mm Hg 2.19% per year
Also reported: Mortality HR 0.73. More AKI/syncope with intensive.
- Subtopic
- BP target
- Design
- Open-label RCT, terminated early at median 3.3 yr
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- ESC 2024 HypertensionESC 2021 PreventionACC/AHA 2025 HypertensionACC/AHA 2019 Primary PreventionACC/AHA 2024 PADACC/AHA 2022 Aortic Disease
- Source
- SPRINT Research Group. N Engl J Med. 2015;373(22):2103-2116.doi 10.1056/NEJMoa1511939
Discussion & critique
Automated office BP: readings ~ 5-10 mm Hg lower than typical clinic BP, so targets don't translate 1:1. Excluded diabetes and stroke history.